drugset / Trial / NCT01763424

Nicotinamide in the Treatment of Psoriasis

NCT01763424

Phase 2/3 Completed 66 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will determine if combination of topical calcipotriol and nicotinamide is more effective than calcipotriol alone in treatment of psoriasis.

Timeline

Start
2011-07
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 0.005 % Topical
Subject Nicotinamide Other / unclassified 4 % Topical

Indications